DNA Damage and Repair in the Brain After Cerebral Ischemia
Journal:
Current Topics in Medicinal Chemistry
Volume:
1
Page:
483-495
Author(s):
Philip K. Liu
Oxytosis: A Novel Form of Programmed Cell Death
Journal:
Current Topics in Medicinal Chemistry
Volume:
1
Page:
497-506
Author(s):
Shirlee Tan, David Schubert and Pamela Maher
Non Peptidic Ligands at the Opioid Receptor Like-1 (ORL-1)
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
363-375
Author(s):
D. Barlocco, L. Toma and G. Cignarella
FKBP Ligands as Novel Therapeutics for Neurological Disorders
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
377-397
Author(s):
C. Christner, T. Herdegen and G. Fischer
Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
225-238
Author(s):
J. Garcia de Yebenes and M. P. Sanchez
Neuroprotective Mechanisms as Treatment Strategy in Alzheimers disease
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
239-246
Author(s):
Agneta Nordberg
Elucidating Neuronal and Vascular Injury Through the Cytoprotective Agent Nicotinamide
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
257-267
Author(s):
Kenneth Maiese, Shi-Hua Lin and Zhao Zhong Chong
The Hereditary Disease Array Group (HDAG) - Microarrays, Models and Mechanisms : A Collaboration Update
Journal:
Current Genomics
Volume:
2
Page:
221-229
Author(s):
Tim- Rasmus Kiehl, James M. Olson and Stefan M. Pulst
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal:
Current Drug Targets
Volume:
2
Page:
241-271
Author(s):
Gene C. Palmer
Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action
Journal:
Current Drug Targets
Volume:
2
Page:
285-298
Author(s):
Keith Williams